At the HealthTech Dinner last week, hosted by GenSearch and PwC Switzerland and, we gathered to explore one of today’s most impactful topics in healthcare: Transforming the future of obesity care.

The evening brought together brilliant minds in Pharma and Life Sciences, with insights shared by Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle from Nestlé Health Science.

Sule Erdim Ersoy captivated the room with a deep dive into the obesity patient journey, underscoring the need for greater awareness, improvement in multi-disciplinary treatment approach and long-term maintenance strategies.

Hans-Juergen Woerle added an exciting angle to the conversation with his exploration of GLP-1’s rising influence. He shared why this trend is not just a hype, but a potentially game-changing approach with significant implications for both healthcare practices and patients’ daily life.

It was an inspiring evening of ideas, collaboration, and vision. Thank you to our speakers and attendees for joining us on this journey toward a new future in obesity care!